Nucana Plc ADR (NCNA)

$4.26 +0.07 (1.67%)
Market Cap 127,000.00
Revenue (ttm) 0.00
Net Income (ttm) -24.28M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 90,200
Avg Vol 539,306
Day's Range N/A - N/A
Shares Out 30,000.00
Stochastic %K 20%
Beta 1.50
Analysts Strong Buy
Price Target $25.00

Company Profile

NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. It applies its ProTide technology to transform prescribed chemotherapy agents and nucleoside analogs into medicines. The company is developing medicines to overcome the limitations of nucleoside analogs and generate anti-cancer metabolites in cancer cells. Its pipeline includes NUC-3373, a chemical entity derived from the nucleoside analog 5-fluorouracil that is in Phase...

Industry: Biotechnology
Sector: Healthcare
Phone: 44 13 1357 1111
Address:
3 Lochside Way, Edinburgh, United Kingdom
ChickenClaw
ChickenClaw Oct. 25 at 7:13 PM
$NCNA Shorts Working On The Weekends To Try And Scare....Not Gonna Work...This Stock Is Ready For 2nd Leg Up...And Bigger This Time.
0 · Reply
TVanda00
TVanda00 Oct. 25 at 4:36 PM
$NCNA Wow this thing recently went from $2.78 to $7.80. Starting to think if you missed that train then you’re left with a bag for a few months or longer. We’ll see….
0 · Reply
TVanda00
TVanda00 Oct. 25 at 3:45 PM
$NCNA The current monthly candle really needs to change before it closes. Bearish as it stands now.
0 · Reply
UnicornProfits
UnicornProfits Oct. 24 at 8:27 PM
What is happening to ticker CMCT right now?! CMCT is breaking out like crazy.. Are they pumping up ticker CMCT for 300% today!? Its insane what's going on in this market.. Looks like all eyes are moving to CMCT now.. Watching: $KLTO $RBNE $NCNA $OMH -----
0 · Reply
ChickenClaw
ChickenClaw Oct. 24 at 7:54 PM
$NCNA Last Chance To Get Em Cheap.
0 · Reply
ChickenClaw
ChickenClaw Oct. 24 at 7:51 PM
$NCNA Get Ready For The Shorts
0 · Reply
GreenEnergy1
GreenEnergy1 Oct. 24 at 7:35 PM
$NCNA Doing great, NCNA is now down just 98.17% from last year!
0 · Reply
ChickenClaw
ChickenClaw Oct. 24 at 7:21 PM
$NCNA Releasing Positive News After Bell On A Friday Would Be Wild.
0 · Reply
ChickenClaw
ChickenClaw Oct. 24 at 7:11 PM
$NCNA Im Showing About 190,000 Shares Traded On My Level 2's
0 · Reply
cycloon
cycloon Oct. 24 at 7:09 PM
$NCNA
0 · Reply
Latest News on NCNA
NuCana Compliant with All Nasdaq Continued Listing Criteria

Sep 5, 2025, 8:00 AM EDT - 7 weeks ago

NuCana Compliant with All Nasdaq Continued Listing Criteria

NuCana to Present Data on NUC-7738's Synergy with PD-1 Inhibitors at the ESMO Congress 2025

Sep 3, 2025, 8:00 AM EDT - 7 weeks ago

NuCana to Present Data on NUC-7738's Synergy with PD-1 Inhibitors at the ESMO Congress 2025

NuCana Reports Second Quarter 2025 Financial Results and Provides Business Update

Aug 20, 2025, 4:05 PM EDT - 2 months ago

NuCana Reports Second Quarter 2025 Financial Results and Provides Business Update

NuCana Announces ADS Ratio Change

Aug 1, 2025, 4:05 PM EDT - 3 months ago

NuCana Announces ADS Ratio Change

NuCana Cancels All Outstanding Series A Warrants Following Strategic ATM Execution

Jul 21, 2025, 8:05 AM EDT - 3 months ago

NuCana Cancels All Outstanding Series A Warrants Following Strategic ATM Execution

NuCana Announces Plan to Implement ADS Ratio Change

Jul 11, 2025, 10:30 AM EDT - 3 months ago

NuCana Announces Plan to Implement ADS Ratio Change

NuCana Reports First Quarter 2025 Financial Results and Provides Business Update

Jun 2, 2025, 4:01 PM EDT - 5 months ago

NuCana Reports First Quarter 2025 Financial Results and Provides Business Update

NuCana Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update

Mar 20, 2025, 4:01 PM EDT - 7 months ago

NuCana Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update

Aurion Biotech Appoints Donald Munoz as Chief Financial Officer

Feb 10, 2025, 7:00 AM EST - 9 months ago

Aurion Biotech Appoints Donald Munoz as Chief Financial Officer

NuCana Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 25, 2024, 7:00 AM EST - 11 months ago

NuCana Reports Third Quarter 2024 Financial Results and Provides Business Update

NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or Docetaxel

Nov 11, 2024, 7:00 AM EST - 1 year ago

NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or Docetaxel

Baillie Gifford's Strategic Acquisition of NuCana PLC Shares

Oct 4, 2024, 12:03 PM EDT - 1 year ago

Baillie Gifford's Strategic Acquisition of NuCana PLC Shares

NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States

Sep 25, 2024, 4:01 PM EDT - 1 year ago

NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States

NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024

Sep 14, 2024, 3:01 AM EDT - 1 year ago

NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024

NuCana Announces Update for Phase 2 Randomized Colorectal Cancer Study

Aug 29, 2024, 4:01 PM EDT - 1 year ago

NuCana Announces Update for Phase 2 Randomized Colorectal Cancer Study

NuCana Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 15, 2024, 4:01 PM EDT - 1 year ago

NuCana Reports Second Quarter 2024 Financial Results and Provides Business Update

NuCana to Present at the Jefferies Global Healthcare Conference

May 30, 2024, 8:36 AM EDT - 1 year ago

NuCana to Present at the Jefferies Global Healthcare Conference

NuCana to Present at TD Cowen's 5th Annual Oncology Innovation Summit

May 21, 2024, 8:00 AM EDT - 1 year ago

NuCana to Present at TD Cowen's 5th Annual Oncology Innovation Summit

NuCana Reports First Quarter 2024 Financial Results and Provides Business Update

May 16, 2024, 4:01 PM EDT - 1 year ago

NuCana Reports First Quarter 2024 Financial Results and Provides Business Update

NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement

May 1, 2024, 4:01 PM EDT - 1 year ago

NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement

NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical Study

Apr 9, 2024, 4:30 PM EDT - 1 year ago

NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical Study

NuCana Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business Update

Mar 20, 2024, 4:01 PM EDT - 1 year ago

NuCana Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business Update

NuCana to Present at TD Cowen's 44th Annual Health Care Conference

Feb 27, 2024, 8:00 AM EST - 1 year ago

NuCana to Present at TD Cowen's 44th Annual Health Care Conference

NuCana: Potential Turnaround In 2024 But Risky

Jan 3, 2024, 2:39 AM EST - 1 year ago

NuCana: Potential Turnaround In 2024 But Risky

NuCana Reports Third Quarter 2023 Financial Results and Provides Business Update

Nov 16, 2023, 4:01 PM EST - 2 years ago

NuCana Reports Third Quarter 2023 Financial Results and Provides Business Update

NuCana Announces Listing Transfer to Nasdaq Capital Market

Nov 10, 2023, 4:01 PM EST - 2 years ago

NuCana Announces Listing Transfer to Nasdaq Capital Market

NuCana to Present at the Jefferies London Healthcare Conference

Nov 8, 2023, 4:01 PM EST - 2 years ago

NuCana to Present at the Jefferies London Healthcare Conference

NuCana to Participate in the Truist Securities 2023 BioPharma Symposium

Nov 1, 2023, 4:01 PM EDT - 2 years ago

NuCana to Participate in the Truist Securities 2023 BioPharma Symposium

NuCana Presents Promising Data on NUC-7738 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023

Oct 16, 2023, 7:00 AM EDT - 2 years ago

NuCana Presents Promising Data on NUC-7738 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023

NuCana Presents Encouraging Data on NUC-3373 in Colorectal Cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023

Oct 13, 2023, 12:30 PM EDT - 2 years ago

NuCana Presents Encouraging Data on NUC-3373 in Colorectal Cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023

NuCana Announces Presentations at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023

Sep 18, 2023, 8:00 AM EDT - 2 years ago

NuCana Announces Presentations at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023

NuCana Reports Second Quarter 2023 Financial Results and Provides Business Update

Aug 16, 2023, 4:01 PM EDT - 2 years ago

NuCana Reports Second Quarter 2023 Financial Results and Provides Business Update

NuCana to Present at the Jefferies Healthcare Conference

Jun 1, 2023, 8:00 AM EDT - 2 years ago

NuCana to Present at the Jefferies Healthcare Conference

NuCana Reports First Quarter 2023 Financial Results and Provides Business Update

May 17, 2023, 4:01 PM EDT - 2 years ago

NuCana Reports First Quarter 2023 Financial Results and Provides Business Update

NuCana Announces Receipt of Nasdaq Notice

May 12, 2023, 4:01 PM EDT - 2 years ago

NuCana Announces Receipt of Nasdaq Notice

NuCana Presents Data at the AACR 2023 Annual Meeting Highlighting Novel NUC-7738 Mechanisms of Action

Apr 14, 2023, 8:00 AM EDT - 2 years ago

NuCana Presents Data at the AACR 2023 Annual Meeting Highlighting Novel NUC-7738 Mechanisms of Action

NuCana Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Business Update

Apr 4, 2023, 4:01 PM EDT - 2 years ago

NuCana Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Business Update

Technical Board of Appeal of the European Patent Office Issues Oral Ruling that NuCana's ‘190 Patent is Not Valid

Mar 24, 2023, 4:30 PM EDT - 2 years ago

Technical Board of Appeal of the European Patent Office Issues Oral Ruling that NuCana's ‘190 Patent is Not Valid

NuCana to Participate in Two Upcoming Investor Conferences

Feb 28, 2023, 8:00 AM EST - 2 years ago

NuCana to Participate in Two Upcoming Investor Conferences

NuCana: Pipeline And Major Gilead Litigation Progressing Nicely

Jan 8, 2023, 4:30 AM EST - 3 years ago

NuCana: Pipeline And Major Gilead Litigation Progressing Nicely

NuCana Announces Receipt of NASDAQ Notice

Jan 6, 2023, 4:01 PM EST - 3 years ago

NuCana Announces Receipt of NASDAQ Notice

NuCana Reports Third Quarter 2022 Financial Results and Provides Business Update

Nov 16, 2022, 4:01 PM EST - 3 years ago

NuCana Reports Third Quarter 2022 Financial Results and Provides Business Update

NuCana Presents Positive Data on NUC-3373 at the 34th EORTC-NCI-AACR Annual Meeting 2022

Oct 26, 2022, 7:00 AM EDT - 3 years ago

NuCana Presents Positive Data on NUC-3373 at the 34th EORTC-NCI-AACR Annual Meeting 2022

NuCana: An Intriguing 'Sum Of The Parts' Story

Sep 22, 2022, 3:40 PM EDT - 3 years ago

NuCana: An Intriguing 'Sum Of The Parts' Story

NuCana Presents Promising Data on NUC-7738 at the European Society of Medical Oncology (ESMO) Annual Meeting 2022

Sep 12, 2022, 10:45 AM EDT - 3 years ago

NuCana Presents Promising Data on NUC-7738 at the European Society of Medical Oncology (ESMO) Annual Meeting 2022

NuCana Announces Presentations at the European Society for Medical Oncology (ESMO) Congress 2022

Sep 6, 2022, 8:00 AM EDT - 3 years ago

NuCana Announces Presentations at the European Society for Medical Oncology (ESMO) Congress 2022

NuCana to Participate in Citi's 17th Annual BioPharma Conference

Aug 31, 2022, 8:00 AM EDT - 3 years ago

NuCana to Participate in Citi's 17th Annual BioPharma Conference

NuCana Reports Second Quarter 2022 Financial Results and Provides Business Update

Aug 17, 2022, 4:01 PM EDT - 3 years ago

NuCana Reports Second Quarter 2022 Financial Results and Provides Business Update

NuCana: Improving Chemotherapy And A Major Patent Litigation Win Against Gilead

Jul 13, 2022, 6:00 AM EDT - 3 years ago

NuCana: Improving Chemotherapy And A Major Patent Litigation Win Against Gilead

Why NuCana Shares Are Rising Today?

Jul 11, 2022, 1:52 PM EDT - 3 years ago

Why NuCana Shares Are Rising Today?

ChickenClaw
ChickenClaw Oct. 25 at 7:13 PM
$NCNA Shorts Working On The Weekends To Try And Scare....Not Gonna Work...This Stock Is Ready For 2nd Leg Up...And Bigger This Time.
0 · Reply
TVanda00
TVanda00 Oct. 25 at 4:36 PM
$NCNA Wow this thing recently went from $2.78 to $7.80. Starting to think if you missed that train then you’re left with a bag for a few months or longer. We’ll see….
0 · Reply
TVanda00
TVanda00 Oct. 25 at 3:45 PM
$NCNA The current monthly candle really needs to change before it closes. Bearish as it stands now.
0 · Reply
UnicornProfits
UnicornProfits Oct. 24 at 8:27 PM
What is happening to ticker CMCT right now?! CMCT is breaking out like crazy.. Are they pumping up ticker CMCT for 300% today!? Its insane what's going on in this market.. Looks like all eyes are moving to CMCT now.. Watching: $KLTO $RBNE $NCNA $OMH -----
0 · Reply
ChickenClaw
ChickenClaw Oct. 24 at 7:54 PM
$NCNA Last Chance To Get Em Cheap.
0 · Reply
ChickenClaw
ChickenClaw Oct. 24 at 7:51 PM
$NCNA Get Ready For The Shorts
0 · Reply
GreenEnergy1
GreenEnergy1 Oct. 24 at 7:35 PM
$NCNA Doing great, NCNA is now down just 98.17% from last year!
0 · Reply
ChickenClaw
ChickenClaw Oct. 24 at 7:21 PM
$NCNA Releasing Positive News After Bell On A Friday Would Be Wild.
0 · Reply
ChickenClaw
ChickenClaw Oct. 24 at 7:11 PM
$NCNA Im Showing About 190,000 Shares Traded On My Level 2's
0 · Reply
cycloon
cycloon Oct. 24 at 7:09 PM
$NCNA
0 · Reply
ChickenClaw
ChickenClaw Oct. 24 at 6:56 PM
$NCNA My Level 2's Are Showing Way More Then 72K Shares Tratded.
0 · Reply
cycloon
cycloon Oct. 24 at 6:26 PM
$NCNA It's time to buy yourself rich.
1 · Reply
chapelp
chapelp Oct. 24 at 6:18 PM
$NCNA low volume across all bio and small cap ... Shorts had run out of " naked shares " ... bottom in
0 · Reply
boki82
boki82 Oct. 24 at 5:24 PM
$NCNA
0 · Reply
Oronero
Oronero Oct. 24 at 4:48 PM
$NCNA I just got a buy alert now🗽🇺🇸
1 · Reply
GI812
GI812 Oct. 24 at 4:39 PM
$NCNA Let's get back to lucky #7. Thankfully, so far, I didn't panic sell when the dip hit.
0 · Reply
ChickenClaw
ChickenClaw Oct. 24 at 4:01 PM
$NCNA
0 · Reply
cycloon
cycloon Oct. 24 at 3:58 PM
$NCNA Acquisition is welcome
0 · Reply
piotrek123082
piotrek123082 Oct. 24 at 3:45 PM
$NCNA maybe sometin' cooking over the weekend
0 · Reply
piotrek123082
piotrek123082 Oct. 24 at 2:57 PM
$NCNA Beautiful, music to my ears
0 · Reply
Markmywordusee
Markmywordusee Oct. 24 at 2:51 PM
$NCNA
0 · Reply
ChickenClaw
ChickenClaw Oct. 24 at 2:31 PM
$NCNA Hoping Leadership Forced This Down To Pick Up Cheap Shares...Knowing What's Coming In The Pipeline.
1 · Reply